Evercore ISI analyst Eric Boyes raised the firm’s price target on Albemarle (ALB) to $100 from $88 and keeps an In Line rating on the shares. Q3 marked a shift from earnings-driven moves among chemicals companies, with two-thirds of about 20 chemical names rallying 6% on average post-results, despite half guiding below expectations for Q4 and negative revisions averaging 12%, the analyst tells investors in an earnings recap note for the group.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALB:
- Albemarle price target raised to $100 from $90 at Wells Fargo
- Albemarle price target raised to $85 from $70 at Scotiabank
- Albemarle price target raised to $120 from $117 at RBC Capital
- Albemarle price target raised to $91 from $87 at Truist
- Early notable gainers among liquid option names on November 7th